Matches in Wikidata for { <http://www.wikidata.org/entity/Q91019263> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q91019263 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q91019263 description "scientific article published on 30 October 2019" @default.
- Q91019263 description "wetenschappelijk artikel" @default.
- Q91019263 description "наукова стаття, опублікована 30 жовтня 2019" @default.
- Q91019263 name "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 name "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 type Item @default.
- Q91019263 label "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 label "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 prefLabel "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 prefLabel "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 P1433 Q91019263-0AA4C90C-B2C6-4790-94F8-EF20AC533833 @default.
- Q91019263 P1476 Q91019263-EBE344D7-EBFE-4249-9E10-FB02D3C09DB8 @default.
- Q91019263 P2093 Q91019263-5CA93EE6-2156-41D9-B33B-4BF46924A4E0 @default.
- Q91019263 P2093 Q91019263-64D1D84A-7724-406D-9935-522C6889410E @default.
- Q91019263 P2093 Q91019263-D62C83C1-9F19-4346-AE71-1D0C0D3A5767 @default.
- Q91019263 P2093 Q91019263-F002A33A-69B4-496C-BC9A-7EC938584714 @default.
- Q91019263 P2860 Q91019263-911D234D-A0D5-49BF-BF59-6A28929EEB48 @default.
- Q91019263 P31 Q91019263-AA0B02EA-7212-47F8-B7C1-85B016D41A50 @default.
- Q91019263 P356 Q91019263-5C047904-31C6-47F6-BB2D-416CEBC6C1FD @default.
- Q91019263 P50 Q91019263-0BC0E106-0F36-4571-A318-C03D2DC563AA @default.
- Q91019263 P577 Q91019263-E7494876-A108-449C-86CD-1115A66FDDB4 @default.
- Q91019263 P698 Q91019263-0BFDF6B9-23DC-4D82-970B-411D6EDE99B4 @default.
- Q91019263 P921 Q91019263-02B88228-9E9C-4B9B-82DF-D90B2C741613 @default.
- Q91019263 P932 Q91019263-EA63BAEF-BC72-4BD7-8632-9824E0768F28 @default.
- Q91019263 P356 S40256-019-00377-X @default.
- Q91019263 P698 31667735 @default.
- Q91019263 P1433 Q2555367 @default.
- Q91019263 P1476 "Bioequivalence of a Newly Developed Dabigatran Etexilate Tablet Versus the Commercial Capsule and Impact of Rabeprazole-Induced Elevated Gastric pH on Exposure in Healthy Subjects" @default.
- Q91019263 P2093 "Aki Yanagihara" @default.
- Q91019263 P2093 "Daisuke Nakayama" @default.
- Q91019263 P2093 "Ippei Ikushima" @default.
- Q91019263 P2093 "Miwa Haranaka" @default.
- Q91019263 P2860 Q92366539 @default.
- Q91019263 P31 Q13442814 @default.
- Q91019263 P356 "10.1007/S40256-019-00377-X" @default.
- Q91019263 P50 Q91019258 @default.
- Q91019263 P577 "2019-10-30T00:00:00Z" @default.
- Q91019263 P698 "31667735" @default.
- Q91019263 P921 Q419345 @default.
- Q91019263 P932 "7266796" @default.